APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients - Zhang, Hongsheng; Shao, Lin; Lin, Zhihao; Long, Quan-Xin; Yuan, Huilong; Cai, Lujian; Jiang, Guangtong; Guo, Xiaoyi; Yang, Renzhi; Zhang, Zepeng; Zhang, Bingchang; Liu, Fan; et al. (Signal transduction and targeted therapy, 2022)
Keywords: 631/250/255; 692/699/255; ACE2; Angiotensin-converting enzyme 2; Apolipoprotein E; Apolipoprotein E4; Cancer Research; Cardiovascular diseases; Cell Biology; Chemokines; Cholesterol; Coronaviruses; COVID-19; Cytokines; Disease transmission; Infections; Inflammation; Internal Medicine; Isoforms; Lipid metabolism; Medicine; Medicine & Public Health; Metalloproteinase; Oncology; Pathology; Risk factors; Severe acute respiratory syndrome coronavirus 2; Spike protein